                               SEQUENCE LISTING

<110> PARDES BIOSCIENCES, INC.
 
<120> INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF   

<130> PARB-004WO

<140>
<141>

<150> 63/195,460
<151> 2021-06-01

<150> 63/179,128
<151> 2021-04-23

<150> 63/173,146
<151> 2021-04-09

<150> 63/172,478
<151> 2021-04-08

<150> 63/171,675
<151> 2021-04-07

<150> 63/129,018
<151> 2020-12-22

<150> 63/091,630
<151> 2020-10-14

<150> 63/067,669
<151> 2020-08-19

<150> 63/039,297
<151> 2020-06-15

<150> 63/036,866
<151> 2020-06-09

<160> 1     

<170> PatentIn version 3.5

<210> 1
<211> 302
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 1
Ala Gly Leu Arg Lys Met Ala Gln Pro Ser Gly Phe Val Glu Lys Cys 
1               5                   10                  15      


Val Val Arg Val Cys Tyr Gly Asn Thr Val Leu Asn Gly Leu Trp Leu 
            20                  25                  30          


Gly Asp Ile Val Tyr Cys Pro Arg His Val Ile Ala Ser Asn Thr Thr 
        35                  40                  45              


Ser Ala Ile Asp Tyr Asp His Glu Tyr Ser Ile Met Arg Leu His Asn 
    50                  55                  60                  


Phe Ser Ile Ile Ser Gly Thr Ala Phe Leu Gly Val Val Gly Ala Thr 
65                  70                  75                  80  


Met His Gly Val Thr Leu Lys Ile Lys Val Ser Gln Thr Asn Met His 
                85                  90                  95      


Thr Pro Arg His Ser Phe Arg Thr Leu Lys Ser Gly Glu Gly Phe Asn 
            100                 105                 110         


Ile Leu Ala Cys Tyr Asp Gly Cys Ala Gln Gly Val Phe Gly Val Asn 
        115                 120                 125             


Met Arg Thr Asn Trp Thr Ile Arg Gly Ser Phe Ile Asn Gly Ala Cys 
    130                 135                 140                 


Gly Ser Pro Gly Tyr Asn Leu Lys Asn Gly Glu Val Glu Phe Val Tyr 
145                 150                 155                 160 


Met His Gln Ile Glu Leu Gly Ser Gly Ser His Val Gly Ser Ser Phe 
                165                 170                 175     


Asp Gly Val Met Tyr Gly Gly Phe Glu Asp Gln Pro Asn Leu Gln Val 
            180                 185                 190         


Glu Ser Ala Asn Gln Met Leu Thr Val Asn Val Val Ala Phe Leu Tyr 
        195                 200                 205             


Ala Ala Ile Leu Asn Gly Cys Thr Trp Trp Leu Lys Gly Glu Lys Leu 
    210                 215                 220                 


Phe Val Glu His Tyr Asn Glu Trp Ala Gln Ala Asn Gly Phe Thr Ala 
225                 230                 235                 240 


Met Asn Gly Glu Asp Ala Phe Ser Ile Leu Ala Ala Lys Thr Gly Val 
                245                 250                 255     


Cys Val Glu Arg Leu Leu His Ala Ile Gln Val Leu Asn Asn Gly Phe 
            260                 265                 270         


Gly Gly Lys Gln Ile Leu Gly Tyr Ser Ser Leu Asn Asp Glu Phe Ser 
        275                 280                 285             


Ile Asn Glu Val Val Lys Gln Met Phe Gly Val Asn Leu Gln 
    290                 295                 300         


